Healthy women
Conditions
Interventions
Intake of Saji juice
Intake of placebo juice
Sponsors
Finess Co, Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Those who are temporarily fatigued or have low vitality due to a desk-bound job (2) Premenopausal women between the ages of 20 and 50 (3) BMI less than 30 kg/m2 (4) Those with relatively stable menstrual cycles (5) Persons who give written voluntary consent to participate in the study (6) Those who can continue to drink SajiJuice
Exclusion criteria
Exclusion criteria: (1) Those who are currently under medication for iron deficiency anemia (2) Those who are currently receiving medication for some disease. (3) Those who are consuming food products containing the ingredients of this test food or health food products. (4) Subjects with irregular menstruation (5) Persons with serious diseases of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system, nervous system or psychiatric disorders. (6) Persons with a history of such diseases (6) Persons with a history of abnormal clinical laboratory values that would be considered problematic for study participation (7) Persons who have a disease under treatment or a history of a serious disease that required medication (8) Persons who may develop allergies related to the study (9) Persons who are judged to be unsuitable as subjects based on the results of the lifestyle questionnaire (10) Subjects who are participating in other clinical studies at the time this study is initiated. (11) Pregnant or planning to become pregnant or breastfeeding during the study period (12) Persons who are judged to be unsuitable to participate in the study by the investigator (or study administrator).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QOL Questionnaire for Daily Life | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood test related to anemia, temporary fatigue when performing work tasks | — |
Countries
Japan
Contacts
Public ContactNibun Shigenori
EAS inc. Clinical Trial Session
Outcome results
None listed